Indivior Pharmaceuticals, Inc.
INDV
$36.76
-$1.07-2.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 89.00M | 102.00M | 43.00M | 18.00M | 47.00M |
| Total Depreciation and Amortization | 4.00M | 5.00M | 5.00M | 5.00M | 5.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 61.00M | -29.00M | 10.00M | 13.00M | 6.00M |
| Change in Net Operating Assets | -163.00M | -299.00M | -97.00M | 122.00M | 17.00M |
| Cash from Operations | -9.00M | -221.00M | -39.00M | 158.00M | 75.00M |
| Capital Expenditure | -20.00M | -24.00M | -20.00M | -17.00M | -5.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing | -19.00M | -24.00M | -20.00M | -17.00M | -5.00M |
| Total Debt Issued | 489.00M | -- | -- | -- | -- |
| Total Debt Repaid | -333.00M | -5.00M | -4.00M | -4.00M | -4.00M |
| Issuance of Common Stock | -- | 0.00 | 1.00M | 0.00 | 1.00M |
| Repurchase of Common Stock | -147.00M | -2.00M | 0.00 | 0.00 | -14.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00M | 2.00M | 0.00 | -1.00M | -- |
| Cash from Financing | 7.00M | -5.00M | -3.00M | -5.00M | -17.00M |
| Foreign Exchange rate Adjustments | -- | 0.00 | -2.00M | 1.00M | -- |
| Miscellaneous Cash Flow Adjustments | 1.00M | -- | -1.00M | 1.00M | -- |
| Net Change in Cash | -20.00M | -250.00M | -65.00M | 138.00M | 53.00M |